1. Home
  2. MAIA vs ROC Comparison

MAIA vs ROC Comparison

Compare MAIA & ROC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MAIA Biotechnology Inc.

MAIA

MAIA Biotechnology Inc.

BUY

Current Price

$1.19

Market Cap

79.0M

Sector

Health Care

ML Signal

BUY

Logo Rank One Computing Corporation Common stock

ROC

Rank One Computing Corporation Common stock

N/A

Current Price

$4.14

Market Cap

78.6M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
MAIA
ROC
Founded
2018
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
79.0M
78.6M
IPO Year
2022
2025

Fundamental Metrics

Financial Performance
Metric
MAIA
ROC
Price
$1.19
$4.14
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
★ $7.75
AVG Volume (30 Days)
★ 695.2K
24.6K
Earning Date
11-06-2026
08-13-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 33.33
N/A
EPS
N/A
★ N/A
Revenue
N/A
★ $16,979,679.00
Revenue This Year
N/A
$21.30
Revenue Next Year
N/A
$72.97
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 23.90
52 Week Low
$0.87
$3.71
52 Week High
$3.19
$7.80

Technical Indicators

Market Signals
Indicator
MAIA
ROC
Relative Strength Index (RSI) 36.82 47.48
Support Level N/A $3.71
Resistance Level $1.48 $4.59
Average True Range (ATR) 0.08 0.25
MACD -0.02 -0.01
Stochastic Oscillator 11.29 33.61

Price Performance

Historical Comparison
MAIA
ROC

About MAIA MAIA Biotechnology Inc.

MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of targeted immunotherapies for cancer, with an initial focus on non-small cell lung cancer (NSCLC), which represents the majority of lung cancer cases. Its asset, ateganosine (THIO, also known as 6-thio-dG or 6-thio-deoxyguanosine), is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The treatment approach involves administering THIO followed by the immune checkpoint inhibitor Libtayo (cemiplimab), which is manufactured and commercialized by Regeneron.

About ROC Rank One Computing Corporation Common stock

Rank One Computing Corp is an American artificial intelligence company. It develops AI systems that analyze visual data to identify and interpret objects and activities. The company's focus is on biometric identity, digital forensics, and real-time video analytics. It uses the term 'Vision AI,' which is an operational AI built for accuracy, speed, and auditability. The company generates revenue from the sale of access to its software platforms, maintenance services, and professional services.

Share on Social Networks: